Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-02-28 @ 11:20 AM
Study NCT ID:
NCT02620293
Status:
COMPLETED
Last Update Posted:
2016-06-03
First Post:
2015-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'submissionTracking': {'submissionInfos': [{'releaseDate': '2017-06-06', 'unreleaseDateUnknown': True}, {'resetDate': '2018-11-09', 'releaseDate': '2018-04-12'}], 'estimatedResultsFirstSubmitDate': '2017-06-06'}}, 'conditionBrowseModule': {'meshes': [{'id': 'D004485', 'term': 'Eczema'}], 'ancestors': [{'id': 'D003872', 'term': 'Dermatitis'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}, {'id': 'D017443', 'term': 'Skin Diseases, Eczematous'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE1'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 33}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2016-04'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2016-05', 'completionDateStruct': {'date': '2016-04', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2016-06-02', 'studyFirstSubmitDate': '2015-09-09', 'studyFirstSubmitQcDate': '2015-11-30', 'lastUpdatePostDateStruct': {'date': '2016-06-03', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2015-12-03', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2016-04', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Skin tolerance assessment using the ISO 10993 scoring system through visual assessment', 'timeFrame': '47 hours', 'description': 'Irritation of test products assessed using the Cutaneous Irritancy Index (scores range from \\<1 which is non-irritant to \\>4 strongly irritating'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'conditions': ['Eczema']}, 'descriptionModule': {'briefSummary': 'This is an open label, non-comparative investigation to determine the tolerance of Eczema Repair Emollient on healthy subjects with dry/atopic and very dry/atopic skin.\n\nThe Eczema Repair Emollient will be applied for 47 hours under occlusion. Skin tolerance will be assessed immediately and 1 hour, 24, 48 and 72 hours after patch removal.', 'detailedDescription': "At immediate, 1, 24, 48, and 72 hours post-test patch removal (date \\& time of each assessment will be recorded), each test site will be scored for erythema and oedema by the trained investigator using the ISO 10993 scoring system.\n\nPrimary Endpoint The irritation of the test product according to the Cutaneous Irritancy Index value. The test product should be graded as 'non-irritant' and confirmed by the study dermatologist."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '65 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Subjects who are able to give written informed consent and from whom written informed consent has been obtained\n* Generally healthy male and female subjects between the ages of 18 and 65 years inclusive\n* Subjects assessed by the dermatologist as having dry/atopic and very dry/ atopic skin\n* Subjects who are able to understand the study, co-operate with the study procedures and are able to attend for all study assessments\n\nExclusion Criteria:\n\n* Subjects with active Psoriasis or other active skin disorders or with present skin tumours or malignant disease or a history of those\n* Subjects taking antihistamine or corticoids, any medication for the treatment of diabetes mellitus, immuno-suppressive drugs or any other medication which in the opinion of the dermatologist may affect the test results.\n* Subjects with active skin disorders or a history of skin disorders (e.g. psoriasis, eczema, vitiligo, pityriasis versicolor, acne) which in the opinion of the trainee dermatologist or SIT personnel may affect the test results'}, 'identificationModule': {'nctId': 'NCT02620293', 'briefTitle': 'A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin', 'organization': {'class': 'INDUSTRY', 'fullName': 'Reckitt Benckiser Healthcare (UK) Limited'}, 'officialTitle': 'A 47 Hour, Single Application, Occlusive Forearm Skin Patch Test to Assess, Under Dermatological Control, the Acute Cutaneous Tolerance of Project Storm on the Forearm of Adult Subjects With Dry/Atopic and Very Dry/Atopic Skin', 'orgStudyIdInfo': {'id': '09224-01'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Eczema Emollient', 'description': 'Eczema Repair Emollient', 'interventionNames': ['Device: Eczema Repair Emollient']}], 'interventions': [{'name': 'Eczema Repair Emollient', 'type': 'DEVICE', 'description': 'An Emollient', 'armGroupLabels': ['Eczema Emollient']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Hamburg', 'country': 'Germany', 'facility': 'Skin Investigation Technology', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}], 'overallOfficials': [{'name': 'Dörte Segger, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Skin Investigational Technology'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Reckitt Benckiser Healthcare (UK) Limited', 'class': 'INDUSTRY'}, 'collaborators': [{'name': 'Skin Investigation Technology', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'SPONSOR'}}}, 'annotationSection': {'annotationModule': {'unpostedAnnotation': {'unpostedEvents': [{'date': '2017-06-06', 'type': 'RELEASE'}, {'type': 'UNRELEASE', 'dateUnknown': True}, {'date': '2018-04-12', 'type': 'RELEASE'}, {'date': '2018-11-09', 'type': 'RESET'}], 'unpostedResponsibleParty': 'Reckitt Benckiser Healthcare (UK) Limited'}}}}